Filing Details
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:UNCY
Unicycive Therapeutics, Inc. (UNCY) Reports Material Event to SEC
Filing Details Unicycive Therapeutics, Inc. (NASDAQ:UNCY) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market…
Market Context
Unicycive Therapeutics, Inc.'s stock currently trades at $5.73 with a market capitalization of $113.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Unicycive Therapeutics, Inc.'s stock.
All SEC filings for Unicycive Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View UNCY Stock Page
Frequently Asked Questions
Where can I read UNCY's SEC filings?
Browse all filings on our UNCY SEC filings page.
What types of SEC filings does Unicycive Therapeutics, Inc. file?
Public companies like Unicycive Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.